Clinical Trial

Surgiphor Us in TSA

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Bacteria is occasionally present in the shoulder during shoulder arthroplasty surgery and is hypothesized to increase the risk of failure of the prosthesis. Surgiphor (sterile Povidone-Iodine) wound irrigation, is a solution used in orthopaedic surgery and other surgical fields to kill bacteria intraoperatively. The Iodine dissociates from complex and has antimicrobial properties, causing cell death of bacteria, fungi, and viruses through interactions with proteins, nucleotides, and fatty acids in the cytoplasm and cytoplasmic membrane. This study examines the use of Povidone-Iodine during primary shoulder arthroplasty.
Trial Details
NCT Number NCT06601803
Lead Sponsor Rothman Institute Orthopaedics
Conditions Total Shoulder Arthroplasty, Shoulder Infection, Povidone Iodine
Enrollment 126 participants
Start Date 2024-09-16
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-19